Medicare Advantage Accelerates Claims Approval for Exoskeleton Devices
Lifeward reports accelerated Medicare Advantage claims approvals for ReWalk 7 Exoskeleton, improving access and payment timelines in 2025.
Lifeward reports accelerated Medicare Advantage claims approvals for ReWalk 7 Exoskeleton, improving access and payment timelines in 2025.
Stay informed with Pharma Pulse podcast, delivering the latest trends in pharmaceutical access, supply chain logistics, data technology, and healthcare innovation for industry professionals.
CVS Health's Aetna expands its Clinical Collaboration program to ten hospitals by 2025, targeting reductions in Medicare Advantage hospital readmissions and length of stay through embedded nursing care during discharge transitions.
Aetna scales its Clinical Collaboration program to ten hospitals, aiming to reduce 30-day Medicare readmissions and enhance care transitions for Medicare Advantage members by embedding nurses within hospital teams.
MaineHealth's Trellis Health introduces a membership-based primary care system aiming to enhance access, reduce specialist visits, and improve provider work-life balance through direct payment models. This innovative approach may influence broader primary care payment reforms.
Explore how the aging U.S. population is fueling AI healthcare innovation, annuity growth, and healthspan technologies, creating new investment opportunities in longevity markets.
Priority Health expands beyond traditional coverages by embracing whole-person care and digital partnerships, addressing chronic conditions and simplifying member navigation in health plans.
Waterdrop Inc.'s AI-driven innovations in Insurtech and healthcare have earned a feature in Harvard Business School's Case Collection, showcasing transformative digital strategies driving growth and operational efficiency in insurance.
CMS approves Medicare coverage for Abbott's TriClip G5 device, expanding access to minimally invasive tricuspid valve repair for eligible beneficiaries.
Clover Health launches a New Jersey pharmacy pilot targeting medication adherence and hospitalization cuts to improve Medicare Advantage margins and unlock growth potential.